Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Identify situations where TRI provides a fuller view of performance than a price index, especially when dividends and compounding matter to total returns.
26,863 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Shopify’s $120 billion revival is unfolding with a burst of revenue and user growth, catching short sellers by surpri...
As two iconic U.S. food brands, Krispy Kreme and McDonald’s attract very different types of investors. This article b...
Many retirees fixate on social security everyone fears, but the real danger lies in a mix of health costs, market swi...
Austin Niemiec returns to lead Rocket Pro as executives depart, signaling a strengthened wholesale channel amid a vol...
A private defense contractor is pushing the Navy toward autonomous, unmanned surface ships. This article explains the...
As 2026 unfolds amid market swings and thinner savings, Suze Orman’s call to delay Social Security to 70 sharpens the...
The Trump administration has paused $259.5 million in Minnesota's Medicaid funding amid fraud concerns, demanding a c...
A practical, no-fluff look at national health investors (nhi) after its Q4 update. We break down occupancy, rent coll...
The world’s hottest stock market dropped about 7% over two trading days as international investors pulled funds, sign...
Senate Democrats rolled out a sweeping housing plan to curb corporate ownership of single-family homes and redirect t...
Financial advisors outline three critical retirement moves for baby boomers to secure income and minimize risk as mar...